Biofrontera (BFRI) Total Current Liabilities (2020 - 2025)
Historic Total Current Liabilities for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $12.6 million.
- Biofrontera's Total Current Liabilities rose 1378.72% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 1378.72%. This contributed to the annual value of $12.0 million for FY2024, which is 3354.16% down from last year.
- Biofrontera's Total Current Liabilities amounted to $12.6 million in Q3 2025, which was up 1378.72% from $19.7 million recorded in Q2 2025.
- In the past 5 years, Biofrontera's Total Current Liabilities ranged from a high of $29.1 million in Q3 2023 and a low of $9.3 million during Q2 2024
- Over the past 5 years, Biofrontera's median Total Current Liabilities value was $13.9 million (recorded in 2021), while the average stood at $15.5 million.
- Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 21303.17% in 2021, then plummeted by 6212.06% in 2024.
- Biofrontera's Total Current Liabilities (Quarter) stood at $13.8 million in 2021, then soared by 51.01% to $20.9 million in 2022, then dropped by 13.43% to $18.1 million in 2023, then crashed by 33.54% to $12.0 million in 2024, then grew by 4.43% to $12.6 million in 2025.
- Its Total Current Liabilities was $12.6 million in Q3 2025, compared to $19.7 million in Q2 2025 and $11.0 million in Q1 2025.